Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level908 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (459)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03851471 | Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma | completed | Early Phase 1 | 10 | Zhong WangOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT03888859 | ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma | completed | Early Phase 1 | 12 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT04518774 |
| Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial |
| unknown |
| Early Phase 1 |
| 8 |
| Beijing 302 HospitalOTHER |
| 1 |
| Aug 19, 2020 |
| clinicaltrials |
| NCT02927626 | Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma(YYFZTIHBVHCC) | completed | Early Phase 1 | 132 | Beijing Ditan HospitalOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT03965546 | ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer | unknown | Early Phase 1 | 27 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT04048317 | Effectiveness of Drug Eluting TACE in Primary HCC | unknown | Early Phase 1 | 75 | Assiut UniversityOTHER | 0 | Aug 7, 2019 | clinicaltrials |
| NCT03672305 | Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC | unknown | Early Phase 1 | 50 | The Second Hospital of Nanjing Medical UniversityOTHER | 0 | Sep 18, 2018 | clinicaltrials |
| NCT01962649 | A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01247298 | A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma(RAD 0902) | completed | Early Phase 1 | 17 | University of Alabama at BirminghamOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT01968629 | 24hr Imaging Of HCC After EOVIST | withdrawn | Early Phase 1 | 0 | Massachusetts General HospitalOTHER | 1 | Sep 23, 2015 | clinicaltrials |
| NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | completed | Early Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT01337492 | Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT) | terminated | Early Phase 1 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 21, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Apr 9, 2021source: clinicaltrials